Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 50Active not recruiting 28Completed 13Not yet recruiting 12Withdrawn 2Terminated 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastases From Colorectal Cancer (mCRC) 1

Interventions

Educational Status 5Interviews as Topic 4Methods 3Early Intervention, Educational 3Cisplatin 3Blood Specimen Collection 3pembrolizumab 2Surveys and Questionnaires 2Standard of Care 2Nivolumab 2Music Therapy 2Magnetic Resonance Imaging 2Gemcitabine 2Counseling 2zilucoplan 1tislelizumab 1somapacitan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1futibatinib 1fluorodopa F 18 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1dalpiciclib 1brexucabtagene autoleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Irinotecan × 90 days × Clear all
NCT07441369 2026-04-27

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Fudan University

Phase 2 Enrolling by invitation
16 enrolled
Gastrointestinal

Liver Metastases From Colorectal Cancer (mCRC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡